1. Home
  2. AVAV vs PTGX Comparison

AVAV vs PTGX Comparison

Compare AVAV & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AeroVironment Inc.

AVAV

AeroVironment Inc.

N/A

Current Price

$166.90

Market Cap

8.6B

Sector

Industrials

ML Signal

N/A

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

N/A

Current Price

$137.32

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVAV
PTGX
Founded
1971
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.5B
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
AVAV
PTGX
Price
$166.90
$137.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
17
13
Target Price
$316.88
$108.23
AVG Volume (30 Days)
1.4M
547.4K
Earning Date
03-10-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.35
Revenue
N/A
N/A
Revenue This Year
$135.55
$874.25
Revenue Next Year
$14.90
N/A
P/E Ratio
N/A
$2,746.40
Revenue Growth
N/A
N/A
52 Week Low
$135.20
$50.49
52 Week High
$417.86
$143.29

Technical Indicators

Market Signals
Indicator
AVAV
PTGX
Relative Strength Index (RSI) 57.37 63.87
Support Level $138.24 $127.98
Resistance Level $220.08 N/A
Average True Range (ATR) 8.83 5.60
MACD 3.10 -0.40
Stochastic Oscillator 77.54 93.64

Price Performance

Historical Comparison
AVAV
PTGX

About AVAV AeroVironment Inc.

AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: